Crossref
Rare Absence of CD79alpha in B-ALLs is not Associated with Altered Prognosis
Iranian Journal of Blood and Cancer · 2022
DOI: 10.58209/ijbc.14.1.29 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iranian Journal of Blood and Cancer, 2022. Verfasst von Neha Garg und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Garg, N., Shastri, M., kotru, M., & Gupta, R. (2022). Rare Absence of CD79alpha in B-ALLs is not Associated with Altered Prognosis. Iranian Journal of Blood and Cancer. https://doi.org/10.58209/ijbc.14.1.29
Vancouver
Garg N, Shastri M, kotru M, Gupta R. Rare Absence of CD79alpha in B-ALLs is not Associated with Altered Prognosis. Iranian Journal of Blood and Cancer. 2022. doi:10.58209/ijbc.14.1.29
BibTeX
@article{Garg2022,
author = {Garg, Neha and Shastri, Malvika and kotru, Mrinalini and Gupta, Richa},
title = {Rare Absence of CD79alpha in B-ALLs is not Associated with Altered Prognosis},
journal = {Iranian Journal of Blood and Cancer},
year = {2022},
doi = {10.58209/ijbc.14.1.29}
}
EUVIMED